Hi, Continue visiting your profile
user

Login

Email

Password

Create account
Forget password
AnyGenes
  • email login

Advance your research in cell signaling and biomarkers with AnyGenes®​

Cell signaling research requires precise and reliable tools. AnyGenes® provides over 1,000 experimentally validated qPCR arrays and high-performance reagents, delivering reproducible results even with low-input or challenging samples. Our solutions help researchers uncover molecular pathways, immune response mechanisms, and biomarkers, accelerating breakthroughs in molecular biology.

Trusted partner for over 17 years

  • 17+ years of expertise in molecular and cellular biology
  • 1,000+ ready-to-use qPCR arrays
  • Cited in 100+ scientific publications
  • Featured in top journals: Nature, Circulation, PLoS, Redox Biology…
AnyGenes has developed a large catalog of molecular biology reagents and assays.

Why researchers choose AnyGenes® for cell signaling research

  • Unique two-exon primer design ensuring higher specificity
  • Free data analysis software included with all qPCR array kits
  • 1,000+ validated qPCR arrays covering human, mouse, rat, pig… & lncRNA
  • Proven impact: cited in top journals (Nature, Circulation, PLoS, Redox Biology…)
  • End-to-end support: from assay design to biomarker validation
  • Dedicated technical support and consultation to optimize your experiments

Free data analysis tools for smarter cell signaling research

Get more than qPCR arrays and gain powerful data analysis software included with every kit. Therefore, you can:

  • Visualize, compare, and interpret results quickly
  • Accelerate biomarker discovery and signaling pathway research
  • Export data for publications and reports
Explore our free data analysis tools

Case studies: real-world impact of AnyGenes® qpcr arrays

  • Nature Communications (2021), Garcia P et al.

Using AnyGenes® qPCR arrays, researchers uncovered genome-wide transcriptome changes in Cornelia de Lange Syndrome. Moreover, our arrays enabled precise gene expression profiling even with rare or low-input samples.

  • Circulation (2015), Ranchoux B et al.

SignArrays® facilitated detailed analysis of endothelial signaling pathways in pulmonary hypertension studies, providing key insights for translational research and potential therapeutic targets.

  • PLoS One (2024), Pan-Lizcano R et al.

Validated lncRNA qPCR assays allowed efficient quantification of lncRNAs in acute myocardial infarction patients, supporting rapid biomarker discovery.

Explore all case studies

Our solutions for cell signaling and biomarker research

  • Signaling pathway qPCR arrays: Analyze key cell signaling and molecular mechanisms with precision
  • Experimentally validated primer sets: Reliable design for any gene in any species
  • Pre-amplification kits: Unlock insights from low-input RNA
  • Perfect Master Mixes: Consistency across all qPCR runs
  • lncRNA qPCR assays: Robust profiling of long non-coding RNAs
  • Biomarker services: Comprehensive support for your projects
Explore all molecular signaling qPCR solutions

Our detailed solutions for cell signaling research

AnyGenes Signaling pathway qPCR arrays for cell signaling and biomarkers, compatible with all qPCR instruments.

Signaling pathways qpcr arrays

  • High-precision qPCR arrays for gene expression
  • Compatible with 96- or 384-well formats and all qPCR instruments
  • Accurate analysis of key cellular signaling and molecular pathways

Discover our SignArrays® qPCR  arrays

AnyGenes® high-precision qPCR Master Mix for cell signaling and biomarker research

qPCR MASTER MIXES

  • Optimize your qPCR experiments with precision and reliability
  • Ensure consistency and reproducibility across all your tests
  • Ideal for all qPCR applications and instruments

Explore our Perfect Master Mixes

AnyGenes® SpeAmp® qPCR pre-amplification kit for cell signaling and biomarker research

SpeAmp® Pre-amplification kits NEW!

  • Profile up to 4 signaling pathways using only 5 ng of RNA
  • Reliable results even from rare or challenging samples
  • Ideal for multiplexing and complex studies

Discovre our Pre-Amplification Kits

Get the gene expression profile for any genes and any species with AnyGenes qPCR Validated Primers.

Validated primers sets

  • Ensure accurate gene expression analysis
  • Experimentally validated primers for any gene and species
  • Available individually or in complete sets

Browse our Validated Primer Sets

AnyGenes® microbiome qPCR analysis for cell signaling and biomarker research

Microbiome analysis NEW!

  • Fast and precise profiling for biomarker discovery
  • qPCR kits available in multiple formats
  • Compatible with all standard qPCR instruments
Discover our Microbiota Assays
AnyGenes® Mycoplasma detection qPCR array

Mycoplasma detection kits

  • Protect your cell cultures via qPCR or PCR
  • Reduce contamination risks and false positives
  • Quick results in less than 2 hours

Check our MycoDiag Assays

AnyGenes® qPCR LncRNA kits for cell signaling and biomarker research

LncRNA qPCR kits

  • Robust profiling of long non-coding RNAs
  • Individual primers and ready-to-use qPCR arrays
  • Compatible with all standard qPCR instruments
Discover our LncRNA qPCR kits
AnyGenes® biomarker analysis services for cell signaling and biomarker research

Biomarker analysis services

  • Comprehensive support from cell culture to data analysis
  • Tailored solutions for complex projects
  • Support for biomarker discovery and translational research

Explore our Services

Research applications in cell signaling and biomarker discovery

  • Cancer and apoptosis pathways
  • Inflammation and immune response signaling
  • Neurodegenerative and autoimmune mechanisms
  • Cellular stress and survival pathways
  • Drug development and biomarker validation

Customize your own signaling pathways (SignArrays®) with the factors of your choice!
Simply download and complete our Personalized SignArrays® information file and send it at [email protected] to get started on your project.

,, CUSTOMER TESTIMONIAL ,,

Our client's satisfaction is our priority, see below:

★ ★ ★ ★ ★

“ I am highly satisfied with the exceptional services provided by AnyGenes®. Their bespoke products and insightful advices have significantly contributed to my research endeavors. The team at AnyGenes is consistently professional, approachable, and highly responsive, always available to address any needs promptly.

The customized SignArrays developed by AnyGenes were pivotal in conducting critical analyses that were published in high-impact journals (doi: 10.1161/CIRCULATIONAHA.114.008750 and doi: 10.1165/rcmb.2019-0015OC).

These signaling pathways meticulously crafted to meet my specific requirements, enabled comprehensive studies on the modulation of endothelial-mesenchymal transition, BMP signaling pathways, and integrated stress response. ”

Inserm
Dr Frédéric Perros
Research Director INSERM Laboratory CarMeN "Research Laboratory in Cardiovascular, Metabolism, Diabetology, and Nutrition" at the University of Lyon.
★ ★ ★ ★ ★
“ I deeply appreciate the outstanding support provided by AnyGenes®. Their expertise and thoughtful guidance have been instrumental in advancing my research. The team at AnyGenes maintains a high level of professionalism, remains easily accessible, and responds promptly to any inquiries, ensuring a seamless experience.
The customized SignArrays developed by AnyGenes played a crucial role in analyzing 2D and 3D neural cells derived from patients with neurodevelopmental disorders, as well as in the development of a trilineage Q-PCR array. Precisely designed, these arrays provided valuable insights into NPC stress responses and pathomechanisms. Additionally, the trilineage array served as a crucial quality control tool for iPSC characterization. ”
Inserm
Dr Aurélie de Thonel
CR1 INSERM - UMR7216 Epigenetic and cell fate, Resaerch laboratory V. Mezger – “Interface between Development & Environment” at the University of Paris Cité.
★ ★ ★ ★ ★
“ Our team has been using the MycoDIAG reagent for more than one year to detect the presence of mycoplasma in our cell cultures. We are very satisfied with the quality of the reagent, the delivery times and the response time of the AnyGenes team to orders or technical questions. ”
AP-HP hopital bicètre
Dr Elise Lebigot
Biologiste, Biochemistry department, Bicetre Hospital, APHP. Paris Saclay.

NEWS

1- FORUM LABO PARIS 28-30 MARCH 2023

Please join us at our booth #H105, hall H, to learn more about AnyGenes’s products and molecular services

2- 7th Drug Discovery Summit, 2022-Madrid

AnyGenes will participate to the 7th Drug Discovery Summit, 2022-Madrid. Dr NAIMI, will give a talk on the importance of signaling pathways and biomarkers in the process of drug development, by using AnyGenes molecular platform

3- Importation of biological samples

AnyGenes obtained from The Ministry of Agricultural the authorisation to import biological samples from outside the European Union

4- Distribution agreement with Hölzel Diagnostika

We welcome Hölzel Diagnostika Handels GmbH as new distributor of AnyGenes products and services in Germany, Austria and Switzerland

5- BIO-Europe Spring 2020

AnyGenes will be present at BIO-Europe Spring 2020

6- AnyGenes products and services in JAPAN

We are proud to have signed an agreement with the company Funakoshi, Co, Ltd, for the distribution of AnyGenes products and services in JAPAN

7- BIOFIT 2018, LILLE, 4-5 December

AnyGenes team will be present at BioFIT Event 2018 at Lille, FRANCE

8- Specific Pre-amplification kit

You have small quantity of biological sample but many signaling pathways to explore? AnyGenes® team is proud to help you with our new range of cDNA pre-amplification SpeAmpn system to perform high-throughput analysis with very small amounts of biological material (5 ng RNA) or few cells.

9- MEDICA 2017/ Dûsseldorf, GERMANY, 13-16 NOV

AnyGenes® team was present at MEDICA 2017, the key world forum for medicine. AnyGenes® stays informed of all the news, innovative projects, latest technologies and issues in medical fields in order to offer you innovative products and tools.

10- BioJapan/ Regenerative Medicine Japan 2016

AnyGenes® has been selected by the EU-Japan centre, for BtoB meetings at Osaka from 9-11 October, and to present its products (SignArrays®) and its multi-biomarkers clinical tests at BioJapan 2016, October 12-14, Yokohama, JAPAN.

11- Chinese Medicine Conference 2016

Dr Ju Liya has held a conference at the 2nd World Forum on Astragalus membranaceus, 10 June 2016 at Beijing CHINA. Dr Ju Liya had talked about interesting results from in vitro analysis of compounds from chinese medicine by using AnyGenes® molecular platform.

12- Products

Discover now our various signaling pathways (SignArrays®) and Highly sensitive and specific assay kits for specific gene quantification by real time qPCR array.

  • – Ínigo-Catalina L et al. DINCH Exposure Triggers Inflammatory, Oxidative, and Apoptotic Pathways in the Liver of Long-Evans Lactating Rats and Their Offspring. Int. J. Mol. Sci. (2024) 25(23):13017
  • – Grando L et al. The impact of the EVLP on the lung microbiome and its inflammatory reaction. Transpl Int. (2024) 37:12979
  • – Ceron-Codorniu M et al. TDP-43 dysfunction leads to bioenergetic failure and lipid metabolic rewiring in human cells. Redox Biol. (2024) 75:103301
  • – Larriba E et al. Identification of new targets for glioblastoma therapy based on a DNA expression microarray. Comput Biol Med. (2024) 179:108833
  • – Pan-Lizcano R et al. lncRNA CDKN2B-AS1 is downregulated in patients with ventricular fibrillation in acute myocardial infarction. PLoS One (2024) 19(5):e0304041
  • – Sáez-Martínez P et al. Dysregulation of RNA-Exosome machinery is directly linked to major cancer hallmarks in prostate cancer: Oncogenic role of PABPN1. Cancer Lett. (2024) 584:216604
  • – Pinto-Hernandez P et al. miR-29a-3p, a new myokine orchestrating resistance exercise via coordinated metabolic responses. bioRxiv (2024) 592416
  • – Aragón-Herrera A et al. The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats. Biomed Pharmacother. (2023) 161:114535
  • – Rancan L et al. Protective Actions of Cannabidiol on Aging-Related Inflammation, Oxidative Stress and Apoptosis Alterations in Liver and Lung of Long Evans Rats. Antioxidants (2023) 12(10):1837
  • – Masson B et al. Contribution of transient receptor potential canonical channels in human and experimental pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol (2023) 325: L246-L261
  • – Rivas-Chacón LdM et al. Cocoa Polyphenol Extract Inhibits Cellular Senescence via Modulation of SIRT1 and SIRT3 in Auditory Cells. Nutrients (2023) 15:544
  • – Companys‑Alemany J et al. Glial cell reactivity and oxidative stress prevention in Alzheimer’s disease mice model by an optimized NMDA receptor antagonist. Sci Rep. (2022) 12(1):17908
  • – del Mar Rivas-Chacón, L et al. Preventive Effect of Cocoa Flavonoids via Suppression of Oxidative Stress-Induced Apoptosis in Auditory Senescent Cells. Antioxidants (2022) 11:1450
  • – Pérez-Carrillo L et al. Cardiac Sodium/Hydrogen Exchanger (NHE11) as a Novel Potential Target for SGLT2i in Heart Failure: A Preliminary Study. Pharmaceutics (2022) 14: 1996
  • – To-Figueras J et al. Transcriptomic study in explanted liver from a patient with acute intermittent porphyria. JIMD Rep. (2022) 64(1):10-16
  • – Chikhaoui A et al. Inflammatory landscape in Xeroderma pigmentosum patients with cutaneous melanoma. Sci Rep. (2022) 12(1):13854
  • – Roglans N et al. Chronic liquid fructose supplementation does not cause liver tumorigenesis but elicits clear sex differences in the metabolic response in Sprague-Dawley rats. Food Nutr Res (2021) 65
  • – Chen W et al. CircRNA circPTK2 Might Suppress Cancer Cell Invasion and Migration of Glioblastoma by Inhibiting miR-23a Maturation. Neuropsychiatr Dis Treat. (2021) 17: 2767-2774
  • – Reger de Moura C et al. CD147 Promotes Tumor Lymphangiogenesis in Melanoma via PROX-1. Cancers (2021) 13(19): 4859
  • – Linillos-Pradillo B et al. Determination of SARS-CoV-2 RNA in different particulate matter size fractions of outdoor air samples in Madrid during the lockdown. Environ Res (2021) 195:110863
  • – Garcia P et al. Disruption of NIPBL/Scc2 in Cornelia de Lange Syndrome provokes cohesin genome-wide redistribution with an impact in the transcriptome. Nature Communications (2021) 12(1): 4551
  • Vasilopoulou F et al. Microarray Analysis Revealed Inflammatory Transcriptomic Changes after LSL60101 Treatment in 5XFAD Mice Model. Genes (2021) 12(9): 1315-1327
  • – Haijun Wan H et al. CircRNA CircRIMS is Overexpressed in Esophageal Squamous Cell Carcinoma and Downregulate miR-613 Through Methylation to Increase Cell Proliferation. Cancer Manag Res. (2021) 13: 4587-4595
  • -Ribó P et al. Mutation in KARS: A novel mechanism for severe anaphylaxis. J Allergy Clin Immunol. (2021) 147(5): 1855-1864
  • – Bouchet M et al. ERRα Expression in Bone Metastases Leads to an Exacerbated Antitumor Immune Response. Cancer Res. (2020) 80(13): 2914-2926
  • – Tétu P et al. FGF2 Induces Resistance to Nilotinib through MAPK Pathway Activation in KIT Mutated Melanoma. Cancers (2020) 12(5): 1062
  • – Moreno-Rubio J et al. Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer. Cancer Biol Med. (2020) 17(2):444-457
  • – Tong C et al. Repurposing loperamide to overcome gefitinib resistance by triggering apoptosis independent of autophagy induction in KRAS mutant NSCLC cells. Cancer Treat Res Commun. (2020) 25: 100229
  • Ataam AJ et al. Targeted Angiogenesis Gene Expression Profiling of Patients with Chronic Thromboembolic Pulmonary Hypertension. J. Heart Lung Transplant. (2020) 39(4): S31
  • – Martínez-García MA et al. TLR2 and TLR4 Surface and Gene Expression in White Blood Cells after Fasting and Oral Glucose, Lipid and Protein Challenges: Influence of Obesity and Sex Hormones. Biomolecules (2020) 10(1): 111
  • – Reger de Moura C et al. Intermittent Versus Continuous Dosing of MAPK Inhibitors in the Treatment of BRAF-Mutated Melanoma. Transl Oncol. (2019) 13(2): 275-286
  • – Louveau B et al. Baseline Genomic Features in BRAFV600-Mutated Metastatic Melanoma Patients Treated with BRAF Inhibitor + MEK Inhibitor in Routine Care. Cancers (2019) 11(8): E1203
  • – Dupain C et al. Newly identified LMO3-BORCS5 fusion oncogene in Ewing sarcoma at relapse is a driver of tumor progression. Oncogene (2019) 38(47): 7200-7215
  • – Reger de Moura C et al. Discoidin Domain Receptors: A promising target in melanoma. Pigment Cell Melanoma Res. (2019) 32(5): 697-707
  • – Louveau B et al. A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors. Oncotarget (2019) 10(18): 1669-1687
  • – Félix AJ et al. Functional pharmacogenomics and toxicity of PolyPurine Reverse Hoogsteen hairpins directed against survivin in human cells. Biochem Pharmacol. (2018) 155:8-20
  • – Torres RJ & Puig JG. Aicar effect in early neuronal development. Nucleos Nucleot Nucl. (2018) 37(5): 261-272
  • – Delyon J et al. STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network. J Invest Dermatol. (2018) 138(1): 58-67
  • – Mgrditchian T et al. Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner. Proc Natl Acad Sci. (2017) 114(44): 9271-9279
  • – Buart S et al. Transcriptional response to hypoxic stress in melanoma and prognostic potential of GBE1 and BNIP3. Oncotarget (2017) 8(65): 108786-108801
  • – Broséus J et al. VEGF121, is predictor for survival in activated B-cell-like diffuse large B-cell lymphoma and is related to an immune response gene signature conserved in cancers. Oncotarget (2017) 8(53): 90808-90824
  • – Delyon J et al. PDE4D promotes FAK-mediated cell invasion in BRAF-mutated melanoma. Oncogene (2017) 36(23): 3252-3262
  • – Doucet M et al. Quality Matters: 2016 Annual Conference of the National Infrastructures for Biobanking. Biopreserv Biobank (2017) 15(3): 270-276
  • – Delyon J et al. Validation of a preclinical model for assessment of drug efficacy in melanoma. Oncotarget (2016) 7(11): 13069-13081
  • – Xu-Dubois YC et al. Markers of endothelial to mesenchymal transition: evidence for antibody-endothelium interaction during antibody mediated rejection in kidney recipients. J Am Soc Nephrol. (2016) 27(1): 324-332
  • – Mourah S et al. Dramatic Transient Improvement of Metastatic BRAFV600E-Mutated Langerhans Cell Sarcoma under treatment with Dabrafenib. Blood (2015) 126(24): 2649-2652
  • – Delyon J et al. EMMPRIN regulates β1 integrin-mediated adhesion through Kindlin-3 in human melanoma cells. Exp Dermatol. (2015) 24(6): 443-448
  • – Khayati F et al. EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF. Oncotarget (2015) 6(12): 9766-9780
  • – Ranchoux B et al. Endothelial-to-mesenchymal transition in pulmonary hypertension. Circulation (2015) 131(11): 1006-1018
  • – Djaafri I et al. A novel tumor suppressor function of Kindlin-3 in solid cancer. Oncotarget (2014) 5(19): 8970-8985
  • – Milia-Argeiti E et al. EMMPRIN/CD147-encriched membrane vesicles released from malignant human testicular germ cells increase MMP production through tumor-stroma interaction. Biochim Biophys Acta (2014) 1840(8): 2581-2588
  • – Lescaille G et al. EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression. BMC Cancer (2012) 12(115): 1-9
  • – Milia-Argeiti E et al. Imbalance of MMP-2 and MMP-9 expression versus TIMP-1 and TIMP-2 reflects increased invasiveness of human testicular germ cell tumours. Int J Androl. (2012) 35(6): 835-844
  • – Abdelkarim M et al. Invading Basement Membrane Matrix Is Sufficient for MDA-MB-231 Breast Cancer Cells to Develop a Stable In Vivo Metastatic Phenotype. PLoS ONE (2011) 6(8): e23334.
  • – Huet E et al. EMMPRIN Modulates Epithelial Barrier Function through a MMP-Mediated Occludin Cleavage: Implications in Dry Eye Disease. Am J Pathol. (2011) 179(3): 1278-1286
  • – Moreau M et al. b-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells. Int. J. Cancer (2011) 128(6): 1280-1292
  • – Bougatef F et al. EMMPRIN Promotes Melanoma Cells Malignant Properties through a HIF-2alpha Mediated Up-Regulation of VEGF-Receptor-2. PLoS One (2010) 5(8): e12265
  • – Paule B et al. Soluble Isoforms of Vascular Endothelial Growth Factor Are Predictors of Response to Sunitinib in Metastatic Renal Cell Carcinomas. PLoS One (2010) 5(5): e10715
  • – Ma L et al. Antisense Inhibition of Amphiregulin Expression Reduces EGFR Phosphorylation in Transformed Human Breast Epithelial Cells. Anticancer Res. (2010) 30(6): 2101-2106
  • – Bougatef F et al. EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2. Blood (2009) 114(27): 5547-5556